{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T04:26:17Z","timestamp":1783052777118,"version":"3.54.6"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"am","delay-in-days":397,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.pbb.2023.173572","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T11:14:02Z","timestamp":1684926842000},"page":"173572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression"],"prefix":"10.1016","volume":"226","author":[{"given":"Neil B.","family":"Varshneya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif H.","family":"Hassanien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan K.","family":"Layle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon R.","family":"Bassman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Iula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Beardsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pbb.2023.173572_bb0005","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.pbb.2023.173572_bb0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jsat.2017.01.004","article-title":"Characterizing fentanyl use in methadone-maintained clients","volume":"75","author":"Arfken","year":"2017","journal-title":"J. Subst. Abus. Treat."},{"issue":"39","key":"10.1016\/j.pbb.2023.173572_bb0015","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.15585\/mmwr.mm7139a3","article-title":"Notes from the field: overdose deaths involving Para-fluorofentanyl - United States, July 2020\u2013June 2021","volume":"71","author":"Bitting","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"6","key":"10.1016\/j.pbb.2023.173572_bb0020","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jat\/bkaa115","article-title":"A 2017-2019 update on acute intoxications and fatalities from illicit fentanyl and analogs","volume":"45","author":"Brunetti","year":"2021","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.pbb.2023.173572_bb0025","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"10.1016\/j.pbb.2023.173572_bb0030","author":"Centers for Disease Control and Prevention","year":"2023"},{"issue":"3","key":"10.1016\/j.pbb.2023.173572_bb0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/00952990.2021.1891420","article-title":"A cross-sectional analysis of fentanyl analog exposures among living patients","volume":"47","author":"Chhabra","year":"2021","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.pbb.2023.173572_bb9005","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.pbb.2023.173572_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","article-title":"Fentanyl: receptor pharmacology, abuse potential, and implications for treatment","volume":"106","author":"Comer","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2023.173572_bb9010","series-title":"Institute for Laboratory Animal Research; Division on Earth and Life Studies","article-title":"Guide for the Care and Use of Laboratory Animals","author":"Committee for the Update of the Guide for the Care and Use of Laboratory Animals","year":"2011"},{"key":"10.1016\/j.pbb.2023.173572_bb9015","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2021.107101","article-title":"The use of hypercapnic conditions to assess opioid-induced respiratory depression in rats","volume":"111","author":"Crowley","year":"2021","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.pbb.2023.173572_bb0045","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.drugalcdep.2019.01.045","article-title":"Trends in fentanyl and fentanyl analogue-related overdose deaths - Montgomery County, Ohio, 2015-2017","volume":"198","author":"Daniulaityte","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.pbb.2023.173572_bb0050","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/bja\/aen088","article-title":"Spinal cord mechanisms of pain","volume":"101","author":"D\u2019Mello","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.pbb.2023.173572_bb0055","series-title":"Counterfeit Prescription Pills Containing Fentanyls: A Global Threat","author":"Drug Enforcement Administration","year":"2016"},{"key":"10.1016\/j.pbb.2023.173572_bb0060","series-title":"NFLIS Brief: Fentanyl and Fentanyl-Related Substances Reported in NFLIS, 2015\u20132016","author":"Drug Enforcement Administration","year":"2017"},{"key":"10.1016\/j.pbb.2023.173572_bb0065","series-title":"NFLIS Brief: Fentanyl, 2001\u20132015. NFLIS Brief: Fentanyl, 2001\u20132015(March 2017)","author":"Drug Enforcement Administration","year":"2017"},{"key":"10.1016\/j.pbb.2023.173572_bb0070","series-title":"NFLIS-DRUG 2019 Annual Report","author":"Drug Enforcement Administration","year":"2020"},{"key":"10.1016\/j.pbb.2023.173572_bb0075","series-title":"Schedules of Controlled Substances: Placement of 10 Specific Fentanyl-Related Substances in Schedule I, Docket No. DEA\u2013476","author":"Drug Enforcement Administration","year":"2021"},{"key":"10.1016\/j.pbb.2023.173572_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109740","article-title":"Amphetamines modulate fentanyl-depressed respiration in a bidirectional manner","volume":"243","author":"Elder","year":"2023","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2023.173572_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114293","article-title":"Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors","volume":"182","author":"Eshleman","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173572_bb0090","series-title":"EMCDDA\u2013Europol Joint Reports","article-title":"Furanylfentanyl. EMCDDA\u2013Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl) piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl)","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"issue":"4","key":"10.1016\/j.pbb.2023.173572_bb9020","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav. Res. Methods"},{"issue":"2","key":"10.1016\/j.pbb.2023.173572_bb9025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"issue":"5","key":"10.1016\/j.pbb.2023.173572_bb0095","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a011916","article-title":"Systems level neuroplasticity in drug addiction","volume":"3","author":"Feltenstein","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.pbb.2023.173572_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2022.111393","article-title":"Fentanyl analog trends in Washington D.C. observed in needle-exchange syringes","volume":"338","author":"Giltner","year":"2022","journal-title":"Forensic Sci. Int."},{"issue":"5","key":"10.1016\/j.pbb.2023.173572_bb0105","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.neuron.2015.08.001","article-title":"Neural control of breathing and CO2 homeostasis","volume":"87","author":"Guyenet","year":"2015","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.pbb.2023.173572_bb0110","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/dta.2822","article-title":"In vitro pharmacology of fentanyl analogs at the human mu opioid receptor and their spectroscopic analysis","volume":"12","author":"Hassanien","year":"2020","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.pbb.2023.173572_bb0115","series-title":"Drugs most Frequently Involved in Drug Overdose Deaths: United States, 2011\u20132016","author":"Hedegaard","year":"2018"},{"key":"10.1016\/j.pbb.2023.173572_bb0120","series-title":"Regional Differences in the Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2017","author":"Hedegaard","year":"2019"},{"issue":"8","key":"10.1016\/j.pbb.2023.173572_bb0125","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/jat\/bkx050","article-title":"Two hospitalizations and one death after exposure to ortho-fluorofentanyl","volume":"41","author":"Helland","year":"2017","journal-title":"J. Anal. Toxicol."},{"issue":"12","key":"10.1016\/j.pbb.2023.173572_bb9030","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1111\/bph.14219","article-title":"Oxycodone-induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition","volume":"175","author":"Hill","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.pbb.2023.173572_bb9035","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1111\/bph.14224","article-title":"The novel mu-opioid receptor agonist PZM21 depresses respiration and induces tolerance to antinociception","volume":"175","author":"Hill","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pbb.2023.173572_bb9040","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/npp.2015.201","article-title":"Ethanol reversal of tolerance to the respiratory depressant effects of morphine","volume":"41","author":"Hill","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pbb.2023.173572_bb9045","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.14860","article-title":"Fentanyl depression of respiration: comparison with heroin and morphine","volume":"177","author":"Hill","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2023.173572_bb9050","series-title":"Compose a activite pharmacologique a base de 1-arylalcoyl-4-(N-arylalcanamido)-piperidines","author":"Janssen","year":"1964"},{"key":"10.1016\/j.pbb.2023.173572_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jsat.2018.01.005","article-title":"Expected and actual fentanyl exposure among persons seeking opioid withdrawal management","volume":"86","author":"Kenney","year":"2018","journal-title":"J. Subst. Abus. Treat."},{"key":"10.1016\/j.pbb.2023.173572_bb0135","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.forsciint.2018.05.042","article-title":"Abuse of fentanyl: an emerging problem to face","volume":"289","author":"Kuczynska","year":"2018","journal-title":"Forensic Sci. Int."},{"issue":"7","key":"10.1016\/j.pbb.2023.173572_bb0140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jat\/27.7.499","article-title":"Fentanyl use, misuse, and abuse: a summary of 23 postmortem cases","volume":"27","author":"Kuhlman","year":"2003","journal-title":"J. Anal. Toxicol."},{"issue":"8","key":"10.1016\/j.pbb.2023.173572_bb0145","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/jat\/30.8.603","article-title":"Fentanyl-related deaths in Ontario, Canada: toxicological findings and circumstances of death in 112 cases (2002-2004)","volume":"30","author":"Martin","year":"2006","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.pbb.2023.173572_bb0150","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/ajad.13092","article-title":"The increasing prevalence of fentanyl: a urinalysis-based study among individuals with opioid use disorder in New York City","volume":"30","author":"Martinez","year":"2021","journal-title":"Am. J. Addict."},{"issue":"6","key":"10.1016\/j.pbb.2023.173572_bb0155","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1093\/jat\/bkac023","article-title":"Reports of adverse events associated with use of novel psychoactive substances, 2017-2020: a review","volume":"46","author":"Mohr","year":"2022","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.pbb.2023.173572_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jsat.2018.10.007","article-title":"Fentanyl exposure among patients seeking opioid treatment","volume":"96","author":"Ochalek","year":"2019","journal-title":"J. Subst. Abus. Treat."},{"issue":"16","key":"10.1016\/j.pbb.2023.173572_bb0165","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/jama.2020.17477","article-title":"Nonfatal opioid overdoses at an urban emergency department during the COVID-19 pandemic","volume":"324","author":"Ochalek","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.pbb.2023.173572_bb0170","series-title":"The Future of Fentanyl and Other Synthetic Opioids","author":"Pardo","year":"2019"},{"issue":"1","key":"10.1016\/j.pbb.2023.173572_bb0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan","year":"2012","journal-title":"Br. J. Pain"},{"key":"10.1016\/j.pbb.2023.173572_bb9055","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jneumeth.2017.04.007","article-title":"Light and the laboratory mouse","volume":"300","author":"Peirson","year":"2018","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.pbb.2023.173572_bb0180","series-title":"Drug Overdose Deaths Involving Fentanyl, 2011\u20132016","author":"Spencer","year":"2019"},{"issue":"4","key":"10.1016\/j.pbb.2023.173572_bb0185","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1556-4029.2007.00481.x","article-title":"Fentanyl concentrations in 23 postmortem cases from the hennepin county medical examiner\u2019s office","volume":"52","author":"Thompson","year":"2007","journal-title":"J. Forensic Sci."},{"issue":"4","key":"10.1016\/j.pbb.2023.173572_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.15585\/mmwr.mm7104a3","article-title":"Notes from the field: increased incidence of fentanyl-related deaths involving para-fluorofentanyl or metonitazene - Knox County, Tennessee, November 2020-August 2021","volume":"71","author":"Trecki","year":"2022","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"8","key":"10.1016\/j.pbb.2023.173572_bb0195","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/jat\/bkac014","article-title":"Toxicological analysis of fluorofentanyl isomers in postmortem blood","volume":"46","author":"Truver","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"1","key":"10.1016\/j.pbb.2023.173572_bb9060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-3565(25)25010-8","article-title":"Respiratory effects of morphine in awake unrestrained rats","volume":"237","author":"van den Hoogen","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2023.173572_bb0200","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuropharm.2019.03.023","article-title":"Opioid-like antinociceptive and locomotor effects of emerging fentanyl-related substances","volume":"151","author":"Varshneya","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2023.173572_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2021.173242","article-title":"Fentanyl-related substances elicit antinociception and hyperlocomotion in mice via opioid receptors","volume":"208","author":"Varshneya","year":"2021","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2023.173572_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114805","article-title":"Respiratory depressant effects of fentanyl analogs are opioid receptor-mediated","volume":"195","author":"Varshneya","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.pbb.2023.173572_bb0215","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1097\/ADM.0000000000000922","article-title":"Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl","volume":"16","author":"Varshneya","year":"2022","journal-title":"J. Addict. Med."},{"issue":"1","key":"10.1016\/j.pbb.2023.173572_bb0220","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/ADM.0000000000001013","article-title":"Opioid use disorder treatment in the fentanyl era","volume":"17","author":"Varshneya","year":"2023","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.pbb.2023.173572_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173496","article-title":"Structurally diverse fentanyl analogs yield differential locomotor activities in mice","volume":"222","author":"Varshneya","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.pbb.2023.173572_bb9065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/08958378.2017.1282065","article-title":"Effects of inhaled aerosolized carfentanil on real-time physiological responses in mice: a preliminary evaluation of naloxone","volume":"29","author":"Wong","year":"2017","journal-title":"Inhal. Toxicol."},{"key":"10.1016\/j.pbb.2023.173572_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109442","article-title":"Binding preference at the mu-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl","volume":"227","author":"Xie","year":"2023","journal-title":"Neuropharmacology"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130572300059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009130572300059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:43:12Z","timestamp":1758775392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009130572300059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":59,"alternative-id":["S009130572300059X"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2023.173572","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fentanyl analog structure-activity relationships demonstrate determinants of diverging potencies for antinociception and respiratory depression","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2023.173572","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"173572"}}